The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Changes in Menstrual Cycle Length Prior to Menopause Could Help Predict Risk of Atherosclerosis
October 13th 2021In an analysis of SWAN data, investigators found changes in menstrual cycle length within the 5 years preceding a woman's final menstrual period was associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.
Recognizing the Role of PAs in Cardiology With Viet Le, PA-C
October 12th 2021To celebrate National Physician Assistant Week, we reached out to the president of the Association of Physician Assistants in Cardiology for his perspective on the holiday and to reflect on the evolving role of PAs in cardiology.
Pacemaker Implantation Not Linked to Increased Mortality Following TAVR
October 6th 2021An analysis of patient outcomes for those undergoing transfemoral TAVR from 2008-2018 sugggests permanent pacemaker implantation was not associated with an increase in risk of cardiovascular mortality, heart failure, or endocarditis.
Metabolically Healthy Obesity Associated with Increased Risk of Heart Failure, AFib
October 1st 2021Research presented at EASD 2021 suggests patients with metabolically healthy obesity were still at an increased risk of heart failure and atrial fibrillation when compared to their counterparts who had always maintained a healthy weight.
Amplatzer Talisman PFO Occluder and Delivery Sheath Get Nods from FDA
September 30th 2021Abbott announced on September 29 the FDA had granted approval to the Amplatzer Talisman PFO Occluder for use in patients with a PFO at risk of recurrent stroke. This approval was accompanied by the clearance of the Amplatzer Talisman Delivery Sheath.
Metabolically Healthy Obesity Still Carries Increased Risk of Heart Failure, Arrhythmia
September 29th 2021New data presented at EASD 2021 suggests patients with metabolically healthy obesity were at a 34% greater risk of developing new-onset heart failure and a 33% greater risk of new-onset AF than counterparts of healthy weight and no metabolic abnormalities.
The Importance of World Heart Day, With Brett Nowlan, MD
September 28th 2021Although they are often overlooked, awareness days serve an important role in educating the public and drawing attention to overlooked disease states. In a recent interview, Brett Nowlan, MD, reflects on the importance of awareness days.
Increased Insulin Resistance Could Signal Stroke Risk in Patients with Diabetes
September 28th 2021A study from EASD 2021 suggests increased insulin resistance could help predict risk of incident stroke events among adult patients with type 2 diabetes, with results indicating lowest levels of insulin resistance were at a 40% lower risk of stroke compared to those with the highest levels.
Major Weight Loss Could Return Cardiovascular Risk to Normal Levels in Patients with Obesity
September 28th 2021An analysis of NHANES data presented at EASD 2021 details the effects of returning to a healthy weight among patients with obesity compared to those currently with obesity and those who always maintained a healthy weight.